Ozempic Injection 0.25mg SD

Ozempic Injection 0.25mg SD

Ozempic Injection 0.25mg SD, also known as OZEMPIC 胰妥讚 0.25mg SD and オゼンピック皮下注0.25mg SD, contains semaglutide, a glucagon-like peptide-1 receptor agonist, also known as a GLP-1 receptor agonist. It is a prescription medicine manufactured / marketed by Novo Nordisk and is supplied for subcutaneous injection use under the direction of a qualified healthcare professional.

This Japanese SD presentation is a single-dose subcutaneous injection product. According to Japanese medicine information and international drug labeling references, Ozempic 0.25mg SD contains 0.25mg semaglutide in 0.5mL. It is designed for once-weekly subcutaneous administration as prescribed by a healthcare professional. Always refer to the actual product packaging, pharmacy label and patient information leaflet for the final product configuration, pack quantity and usage instructions.

Ozempic belongs to a class of medicines called GLP-1 receptor agonists. These medicines help support blood glucose control in adults with type 2 diabetes by acting through several glucose-dependent mechanisms. Semaglutide may help stimulate insulin secretion when blood glucose is elevated, reduce glucagon secretion, and slow gastric emptying. Treatment should always be part of a healthcare professional’s diabetes management plan.

Product Information

• Product Name: Ozempic Injection 0.25mg SD
• Chinese Name: OZEMPIC 胰妥讚 0.25mg SD
• Japanese Name: オゼンピック皮下注0.25mg SD
• Alternative Japanese Name: オゼンピック皮下注 0.25mg SD
• Brand: Ozempic
• Manufacturer / Brand Owner: Novo Nordisk
• Active Ingredient: Semaglutide
• Japanese Generic Name: セマグルチド
• Strength: 0.25mg
• Volume: 0.5mL per syringe / single-dose presentation
• Dosage Form: Subcutaneous injection
• Route of Use: Subcutaneous use
• Drug Class: GLP-1 receptor agonist
• Product Type: Prescription medicine
• Professional Guidance: Use only as prescribed by a qualified healthcare professional

Key Features

• Contains semaglutide, a GLP-1 receptor agonist
• 0.25mg strength in an SD subcutaneous injection presentation
• Japanese product name: オゼンピック皮下注0.25mg SD
• Manufactured / marketed by Novo Nordisk
• Commonly used as an initiation dose under professional guidance
• For adults with type 2 diabetes according to approved product information
• Generally administered once weekly as directed by a healthcare professional
• For subcutaneous injection into suitable injection areas as instructed
• Prescription medicine requiring medical supervision
• Should be used together with diet, exercise and professional diabetes care guidance where appropriate

Common Medical Use

Ozempic is used for the management of type 2 diabetes in adults according to approved product information and healthcare professional guidance. It may be prescribed together with diet and exercise as part of a diabetes treatment plan. Suitability, dose, treatment duration and monitoring requirements should be determined by a doctor or qualified healthcare professional.

0.25mg Starting Dose Information

The 0.25mg strength is commonly used as an initial starting dose. According to dosing guidance, treatment often begins with 0.25mg once weekly for the first 4 weeks. This starting dose is intended to help the patient begin treatment and improve tolerability before increasing to a higher dose if appropriate.

The 0.25mg dose is generally not considered a maintenance dose. After the initial starting period, a healthcare professional may adjust the dose depending on blood glucose response, treatment tolerance, medical history and the approved product information in the relevant country or region. Do not start, stop or change the dose of Ozempic without medical advice.

How Ozempic Works

Semaglutide is a GLP-1 receptor agonist. It works through several mechanisms that may help improve blood glucose control in adults with type 2 diabetes. It can stimulate insulin secretion when blood glucose is high, reduce glucagon secretion, and slow gastric emptying. These effects may help support post-meal glucose control and overall glycemic management when used as prescribed.

Administration Method

Ozempic Injection 0.25mg SD is for subcutaneous injection only. It is commonly injected under the skin in areas such as the abdomen, thigh or upper arm, as instructed by a healthcare professional. Injection sites should be rotated to help reduce local discomfort or skin irritation. Patients should read the patient information leaflet and receive proper injection training before use.

Weekly Use Guidance

Ozempic is generally used once weekly on the same day each week, as prescribed. The injection may be taken with or without meals according to professional guidance. If a dose is missed, follow the instructions in the patient information leaflet or contact your healthcare professional for advice. Do not inject extra doses unless instructed by a healthcare professional.

Possible Weight Management Effect

Some patients using semaglutide may experience weight reduction during treatment. However, Ozempic should not be promoted or used simply as a cosmetic weight-loss product. Use should follow approved indications and professional medical guidance. For weight management, patients should consult a doctor to determine the appropriate treatment option based on local regulations, medical history and individual health needs.

Important Safety Information

This product is a prescription medicine and should only be used under medical supervision. Do not use Ozempic if you are allergic to semaglutide or any component of the formulation. Medical advice is required before use, especially for patients with a history of pancreatitis, gallbladder problems, kidney problems, stomach or digestive problems, diabetic eye disease, thyroid disease, severe dehydration risk, pregnancy, planning pregnancy or breastfeeding.

Ozempic may increase the risk of low blood glucose when used with insulin or sulfonylurea medicines. Patients using other diabetes medicines should follow their healthcare professional’s monitoring advice and should not adjust medication doses by themselves.

Potential Side Effects

Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal discomfort, stomach pain, reduced appetite, burping, indigestion or injection site reactions. Some side effects may improve as the body adjusts to treatment, but persistent or severe symptoms should be discussed with a healthcare professional.

Seek medical attention immediately if you experience symptoms such as severe abdominal pain that may spread to the back, persistent vomiting, signs of dehydration, severe allergic reaction, breathing difficulty, swelling of the face or throat, vision changes, severe dizziness, fainting, or symptoms of gallbladder problems such as severe upper abdominal pain or yellowing of the skin or eyes.

Who Should Seek Medical Advice Before Use

• People with a history of pancreatitis
• People with kidney disease or dehydration risk
• People with digestive system disorders or severe stomach problems
• People with diabetic retinopathy or eye complications related to diabetes
• People using insulin, sulfonylureas or other blood glucose-lowering medicines
• People with thyroid disease or relevant family medical history
• People who are pregnant, planning pregnancy or breastfeeding
• People with known allergy to semaglutide or any ingredient in the formulation

Storage and Handling

Store according to the product packaging, pharmacy label and patient information leaflet. In general, Ozempic products should be stored under refrigerated conditions before first use and protected from excessive heat, freezing and direct light. Do not use the product if it has been frozen, exposed to unsuitable temperatures, expired, damaged, cloudy, discolored, or if the packaging has been opened or tampered with.

Keep out of reach of children. Used injection devices and needles should be disposed of according to local medical waste, sharps disposal or pharmacy guidance. Do not share injection devices with another person, even if the needle has been changed.

Related Product Categories

Explore more products in our Healthcare Collection, Diabetes Care Collection, and Professional Use Collection.

Important Disclaimer

Ozempic Injection 0.25mg SD is a prescription medicine and should be used only as prescribed by a qualified healthcare professional. This product information is provided for general reference only and should not replace medical advice, diagnosis or treatment. Do not self-prescribe, do not self-inject without proper training, do not adjust the dose without medical advice, and always follow the instructions of your doctor, pharmacist or healthcare provider.